Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat prefrontal cortex and ventral hippocampus.

Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat prefrontal cortex and ventral hippocampus.

J Neurochem. 2015 May 6;

Authors: Hutson PH, Heins MS, Folgering JH

Abstract
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by poor attention, impulse control and hyperactivity. A significant proportion of ADHD patients are also co-morbid for other psychiatric problems including mood disorders and these patients may be managed with a combination of psychostimulants and anti-depressants. While it is generally accepted that enhanced catecholamine signalling via the action of psychostimulants is likely responsible for the cognitive improvement in ADHD, other neurotransmitters including acetylcholine and histamine may be involved. In the present study, we have examined the effect of lisdexamphetamine dimesylate (LDX), an amphetamine pro-drug that is approved for the treatment of ADHD on acetylcholine and histamine efflux in prefrontal cortex and hippocampus alone and in combination with the antidepressant s-citalopram. LDX increased cortical acetylcholine efflux, an effect that was not significantly altered by coadministration of s-citalopram. Cortical and hippocampal histamine were markedly increased by LDX, an effect that was attenuated in the hippocampus but not in prefrontal cortex when coadministered with s-citalopram. Taken together, these results suggest that efflux of acetylcholine and histamine may be involved in the therapeutic effects of LDX and are differentially influenced by the coadministration of s-citalopram. This article is protected by copyright. All rights reserved.

PMID: 25946513 [PubMed – as supplied by publisher]

via http://ift.tt/1PqCGCz